Schrodinger

Schrodinger, established in 1990, is a leading provider of advanced molecular simulation and enterprise software solutions. The company specializes in computational methods to accelerate scientific breakthroughs in drug discovery and materials science. Its technology platform integrates physics-based modeling with machine learning, enabling innovation across pharmaceutical and materials design. Schrodinger's core offerings empower researchers in life sciences and materials research to develop novel drugs and advanced materials more efficiently.

With a global operational footprint spanning the United States, Europe, Japan, and India, Schrodinger maintains strategic partnerships within the biotechnology, pharmaceutical, chemical, and electronics sectors. The company employs between 500-1,000 professionals dedicated to advancing scientific computation. Meet Schrodinger's team to understand the expertise driving their innovative solutions. Their extensive network of business partnerships extends to China and Korea, underscoring their international reach and collaborative approach to scientific advancement.

Operating within the Engineering Software and Software Development & Design industries, Schrodinger generated $254.9M in revenue. The company has secured significant funding rounds, reflecting investor confidence in its technology and market position. Its competitive landscape includes firms like Certara, Wolfram Research, and Comsol, highlighting Schrodinger's role in a dynamic market. Explore financial highlights for detailed insights into their financial performance and investment history. Schrodinger's commitment to computational science positions it as a key player in accelerating research and development across critical scientific fields.